Pre-treatment of cells with 10 μM reverse transcriptase inhibitor AZT or protease inhibitor Nelfinavir blocked viral infection to nearly background levels as measured by Env-GFP from flow cytometry (Figure 1H). The gene discussed is ERVW-1; the disease is viral infectious disease.